Johns Hopkins Medicine is holding a news conference on the first-ever HIV-to-HIV liver transplant
Researchers at the Johns Hopkins University School of Medicine say a new study of more than 1,000 incompatible kidney transplants demonstrates that, despite immunologic challenges, transplanting across human leukocyte antigen (HLA) antibodies may be a significantly better long-term survival option than waiting years for a compatible donor.
Johns Hopkins recently received approval from the United Network for Organ Sharing to be the first hospital in the U.S. to perform HIV-positive to HIV-positive organ transplants. The institution will be the first in the nation to do an HIV-positive to HIV-positive kidney transplant and the first in the world to execute an HIV-positive to HIV-positive liver transplant.
Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon.
Brigitte Sullivan, administrative director of the Johns Hopkins Comprehensive Transplant Center, has been elected as the board chair of the Living Legacy Foundation of Maryland, which encourages state residents to save and enhance lives through organ and tissue donations that honor the legacy of the donors.
More than 123,000 Americans — more than 3,500 of them in Maryland — are on the transplant waiting list for lifesaving organs, a number that is expected to grow despite great advances in biomedical science, treatment and technology. To bring greater awareness to the plight of people with end-stage organ failure and highlight the need for organ donations, The Johns Hopkins Hospital will fly the Donate Life flag throughout the month of April in celebration of National Donate Life Month.
Johns Hopkins scientists have created a free, Web-based tool to help patients decide whether it's best to accept an immediately available, but less-than-ideal deceased donor kidney for transplant, or wait for a healthier one in the future.
An additional 1,000 patients could undergo kidney transplants in the United States annually if hospitals performed more transplants using paired kidney exchanges, new Johns Hopkins research suggests.
Last month, a surgical team led by Johns Hopkins physicians performed The Johns Hopkins Hospital’s first bilateral arm transplant, together with an innovative treatment to prevent rejection of the new limbs.
The Johns Hopkins University’s Institutional Review Board (IRB) has formally approved plans submitted by Johns Hopkins Medicine’s Department of Plastic and Reconstructive Surgery to begin performing facial transplants. The approval, granted in late July, allows the hospital’s facial transplantation team to begin accepting patients for this surgery – for the very first time.
A Johns Hopkins Children’s Center study of patients who received liver transplants from living donors has found that better outcomes need not come with a heftier price tag.
Johns Hopkins researchers say a program they developed that uses personal advocates and community networks to find organ donors for friends and loved ones who need kidney transplants resulted in success for nearly half of the participants in its trial run.
When Harvard University friends Sheryl Sandberg and Andrew M. Cameron, M.D., Ph.D., met up at their 20th college reunion last spring, they got to talking. Sandberg knew that Cameron, a transplant surgeon at Johns Hopkins, was passionate about solving the perennial problem of transplantation: the critical shortage of donated organs in the United States. And he knew that Sandberg, as chief operating officer of Facebook, had a way of easily reaching hundreds of millions of people.
Thousands more American senior citizens with kidney disease are good candidates for transplants and could get them if physicians would get past outdated medical biases and put them on transplant waiting lists, according to a new study by Johns Hopkins researchers.
Kidney disease patients treated at for-profit dialysis centers are 20 percent less likely to be informed about transplant options and referred for the potentially lifesaving operation than those at nonprofit centers, new Johns Hopkins research suggests.
Changing the organ donation process in this country from opt-in — by, say, checking a box on a driver’s license application— to opt-out, which presumes someone’s willingness to donate after death unless they explicitly object while alive, would not be likely to increase the donation rate in the United States, new Johns Hopkins research suggests.
White heart transplant patients under the age of 18 are more than twice as likely to be alive a decade after surgery as their African-American counterparts, new Johns Hopkins research suggests.
Kidney transplants performed using organs from live donors over the age of 70 are safe for the donors and lifesaving for the recipients, new Johns Hopkins research suggests. The study shines new light on a long-ignored potential source of additional organs that could address a profound national shortage.
Johns Hopkins researchers have developed a way to stimulate a rat’s stem cells after a liver transplant as a means of preventing rejection of the new organ without the need for lifelong immunosuppressant drugs. The need for anti-rejection medicines, which carry serious side effects, is a major obstacle to successful long-term transplant survival in people
For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks — those under the age of 50 — actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.
A national transplant policy change designed to give African-American patients greater access to donor kidneys has sliced in half the racial disparities that have long characterized the allocation of lifesaving organs, new Johns Hopkins research suggests.
Hard-to-match kidney transplant candidates who receive a treatment designed to make their bodies more accepting of incompatible organs are twice as likely to survive eight years after transplant surgery as those who stay on dialysis for years awaiting compatible organs, new Johns Hopkins research finds.
Despite concerns that surgeon fatigue is leading to dangerous complications for patients and data showing worse outcomes for many patients who undergo surgery at night, new Johns Hopkins research suggests that — in the case of heart and lung transplants — time of day has no affect on patient survival.
Johns Hopkins researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.
Older, sicker heart-transplant recipients are significantly more likely to be alive a year after their operations if they have their transplants at hospitals that do a large number of them annually, new Johns Hopkins research suggests. These patients fare less well at low-volume centers, the research shows.